Ledger.Open graph →
SEC Form D · filed January 16, 2018

IGM Biosciences A/S

Offering
$2.4M
Sold
$2.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
KONGENS LYNGBY, Netherlands
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Christina H. Topsoe · Kongens Lyngby, NetherlandsDirectorHenrik H. Topsoe · Kongens Lyngby, NetherlandsDirectorHans Kornerup · Kongens Lyngby, NetherlandsExecJakob H. Topsoe · Kongens Lyngby, NetherlandsDirectorHenrik H. Topsoe · Kongens Lyngby, NetherlandsDirectorHans Kornerup · Kongens Lyngby, NetherlandsExecChristina H. Topsoe · Kongens Lyngby, NetherlandsDirectorJakob H. Topsoe · Kongens Lyngby, NetherlandsDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗